Show simple item record

dc.contributor.authorHall, P
dc.contributor.authorSwinson, D
dc.contributor.authorLord, S
dc.contributor.authorMarshall, H
dc.contributor.authorCairns, D
dc.contributor.authorRuddock, S
dc.contributor.authorBatman, E
dc.contributor.authorVelikova, G
dc.contributor.authorPetty, R
dc.contributor.authorWaters, J
dc.contributor.authorWadsley, J
dc.contributor.authorFalk, S
dc.contributor.authorHandforth, C
dc.contributor.authorRoy, R
dc.contributor.authorJoseph, M
dc.contributor.authorKamposioras, K
dc.contributor.authorNicoll, J
dc.contributor.authorTillett, T
dc.contributor.authorCummins, S
dc.contributor.authorGrumett, S
dc.contributor.authorStokes, Z
dc.contributor.authorWaddell, Thomas K
dc.contributor.authorChatterjee, A
dc.contributor.authorGarcia, A
dc.contributor.authorAllmark, C
dc.contributor.authorSeymour, M
dc.date.accessioned2020-01-29T15:17:53Z
dc.date.available2020-01-29T15:17:53Z
dc.date.issued2019en
dc.identifier.citationHall P, Swinson D, Lord S, Marshall H, Cairns D, Ruddock S, et al. Optimizing chemotherapy for frail and elderly patients with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trial. British Journal of Cancer. 2019;121:43912en
dc.identifier.urihttp://hdl.handle.net/10541/622701
dc.language.isoenen
dc.titleOptimizing chemotherapy for frail and elderly patients with advanced gastroesophageal cancer (aGOAC): the GO2 phase III trialen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentUniversity of Edinburgh, Edinburghen
dc.identifier.journalBritish Journal of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record